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Abstract
Familial Dysautonomia (FD) is an autosomal recessive disorder that affects 1/3,600 live births in the Ashkenazi Jewish
population, and leads to death before the age of 40. The disease is characterized by abnormal development and progressive
degeneration of the sensory and autonomic nervous system. A single base pair substitution in intron 20 of the Ikbkap gene
accounts for 98% of FD cases, and results in the expression of low levels of the full-length mRNA with simultaneous
expression of an aberrantly spliced mRNA in which exon 20 is missing. To date, there is no animal model for the disease, and
the essential cellular functions of IKAP - the protein encoded by Ikbkap - remain unknown. To better understand the normal
function of IKAP and in an effort to generate a mouse model for FD, we have targeted the mouse Ikbkap gene by
homologous recombination. We created two distinct alleles that result in either loss of Ikbkap expression, or expression of
an mRNA lacking only exon 20. Homozygosity for either mutation leads to developmental delay, cardiovascular and brain
malformations, accompanied with early embryonic lethality. Our analyses indicate that IKAP is essential for expression of
specific genes involved in cardiac morphogenesis, and that cardiac failure is the likely cause of abnormal vascular
development and embryonic lethality. Our results also indicate that deletion of exon 20 abolishes gene function. This
implies that the truncated IKAP protein expressed in FD patients does not retain any significant biological function.
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Introduction
Familial Dysautonomia (FD), also known as "Riley-Day
syndrome" or "hereditary sensory and autonomic neuropathy
type III" (MIM 223900), is an autosomal recessive disorder that
affects 1/3,600 live births in the Ashkenazi Jewish population. At
birth, babies with FD display poor muscle tone, weak or absent
suck, respiratory congestion due to misdirected swallow, and
difficulty in maintaining body temperature. Pathological findings
from adults and children indicate that within the peripheral
nervous system, individuals with FD suffer from abnormal or
incomplete neuronal development as well as progressive neuronal
degeneration [1-3]. The criteria for diagnosis of FD in older
children are: absence of fungiform papillae on the tongue, absence
of flare after intradermal injection of histamine, decreased or
absence of deep-tendon reflexes, absence of overflow emotional
tears as well as impaired pain and temperature perception [4–9].
Other clinical features include gastrointestinal dysfunction,
gastroesophageal reflux, vomiting crises, recurrent pneumonia,
scoliosis and postural hypotension. In addition to pulmonary
complications, patients sometimes die suddenly apparently due to
cardiac asystole. Despite advances in patient care, progressive
autonomic dysfunction eventually leads to premature death, with
only 50% of patients reaching the age 40 [3].
Mutations in the Ikbkap gene (mapped to human chromosome
9q31) were shown to be the cause of FD [10–11]. In humans, the
Ikbkap gene covers a 68 kb genomic sequence containing 37 exons
and encodes a 150 kD protein named IKAP. In FD, the major
haplotype (representing .98% of the FD cases) is associated with a
T to C transition in position 6 of the donor splice site of intron 20
of the Ikbkap gene. This mutation results in the generation of an
mRNA in which exon 20 (74 bp) is spliced out, along with intronic
sequences, causing a frameshift and producing a truncated protein
of 79 kD [10,11]. This aberrant splicing however is not fully
penetrant since wild-type (WT) Ikbkap mRNA is also observed in
all tissues, albeit at severely reduced levels [11,12].
IKAP (Inhibitor of kappaB kinase complex associated protein)
was initially identified and named on the basis of its reported
ability to bind IkB kinases and to assemble these proteins into an
active kinase complex [13]. However, a later study failed to
confirm the role of IKAP in cytokine-induced NF-kB activation,
and instead suggested that IKAP may be directly involved in RNA
polymerase II transcription elongation [14]. In favor of this
hypothesis, IKAP or IKAP/Elp1 (due to the high homology with
the yeast elongator ELP1), co-purifies with the human Elongator
complex [15,16], and was shown to bind the coding sequences of
genes that are down-regulated in FD fibroblasts [17]. On the other
hand, IKAP is mainly a cytoplasmic protein [13,17,18] suggesting
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may also be involved in other cellular processes. In support of this
notion, cytosolic IKAP co-purifies with proteins involved in cell
migration and cytoskeleton organization [19], and IKAP also
associates with JNK and enhances JNK-mediated stress signaling
[18]. In addition, other putative roles for IKAP as a cytoplasmic
protein include exocytosis and tRNA modification as suggested
based on the functions of its yeast homolog (ELP1) [20–22].
The above-mentioned studies suggest that IKAP may have
distinct cellular functions, but the mechanism(s) altered resulting in
FD remain to be elucidated. So far, there are no animal models
that recapitulate the molecular and pathological findings of FD,
thus a mouse model for FD would be an invaluable tool to dissect
the functions of IKAP and understand the pathological findings of
FD. In the mouse, the Ikbkap gene is located on chromosome 4 in
a region that is syntenic to human chromosome 9q31 [23,24]. The
mouse IKAP protein shows high degree of homology with the
human IKAP, with 80% aminoacid identity. The consensus donor
splice site of intron 20, which is mutated in the major FD
haplotype, is also conserved in the mouse [24]. These findings
suggest that IKAP is likely to play a similar role in the mouse as in
humans.
As part of an ongoing effort to generate a mouse model for FD,
and to further understand the role(s) of IKAP in embryonic and
postnatal development, we have introduced two types of mutations
in the Ikbkap gene, resulting in either loss of expression of Ikbkap,
or expression of an Ikbkap mRNA missing only exon 20.
Homozygous mutants carrying either of the two mutations die
around E10.5 and display identical phenotypic features, including
developmental delay and abnormal brain and cardiovascular
development. Our analyses indicate that IKAP is an essential
protein for mouse embryonic development, that the truncated
IKAP protein does not retain any biological function in
embryogenesis, and that disruption of the canonical Smad4-
dependent TGFb signaling may underlie some of the develop-
mental defects of mutant embryos.
Results
Targeted disruption of the Ikbkap allele
A mouse genomic DNA library (129Sv, Stratagene) was
screened for clones containing the Ikbkap mouse sequence
corresponding to human exons 18–21, and three clones were
isolated and characterized.
The targeting construct used to disrupt the mouse Ikbkap gene
was designed in such a way to include a loxP-flanked neostop
cassette [25] in intron 20 and a loxP site in intron 19 (see materials
and methods and Figure 1A). This strategy was used since it
represents the most efficient way of generating three mutant alleles
with one targeting vector [25]. In summary this strategy is
advantageous since: a) by itself the insertion of the neostop cassette
in the gene destabilizes the mRNA resulting in severe reduction or
elimination of gene expression, as has been seen with other genes
[25–27], b) Cre-mediated recombination between the external
pair of loxP sites would generate a deletion of exon 20 (see below
and Figure 2A), and c) if recombination deletes only the neostop
cassette, a conditional inactivation allele is generated in which
deletion of exon 20 can then be controlled in a spatio-temporal
manner.
After electroporation into ES cells and selection with G418,
correctly targeted clones were identified by Southern blot analyses
(Fig. 1B). Targeted clones carrying the neostop cassette and the
three loxP sites (Ikbkap
3loxP/+) were injected into E3.5 C57BL/6
blastocysts. Chimeric mice generated from the injections trans-
mitted the targeted allele to their progeny. Mice heterozygous for
the Ikbkap
3loxP/+ allele were normal and fertile.
Loss of Ikbkap gene function results in early embryonic
lethality
Heterozygous Ikbkap
3loxP/+ mice were intercrossed to generate
homozygous Ikbkap
3loxP/3loxP mice. Genotyping of the resulting
progeny at P10 and P0 revealed that no homozygous live-born
pups could be recovered from these matings, indicating that the
mutation was incompatible with normal embryonic development.
To determine the timing and cause of the embryonic lethality,
pregnant females were dissected at different embryonic stages. At
E9.5-E10.5, Ikbkap
3loxP/3loxP embryos were recovered at Mendelian
ratio, but no live mutant embryos were obtained after E11.5.
To confirm that the Ikbkap
3loxP/3loxP is a null allele, embryos
derived from Ikbkap
3loxP/+ intercrosses were dissected at E9.5 and
E10.5. After genotyping of extraembryonic tissues, total RNA
from WT and Ikbkap
3loxP/3loxP mutants was reverse-transcribed and
subjected to PCR amplification for mouse Ikbkap using pairs of
primers that span exons 18–23. Our results show that there is no
Ikbkap expression in Ikbkap
3loxP/3loxP mutants, due to the
destabilization of the mRNA caused by the neostop cassette in
intron 20 (Fig. 1D).
Deletion of exon 20 results in a non-functional allele
In FD patients, the underlying mutation (responsible for over
98% of FD cases) causes skipping of exon 20, leading to a frame
shift and the expression of a truncated protein of 79 kD.
Although the truncated protein is detected in tissues where
skipping of exon 20 is predominant [10], it is not known whether
this truncated protein retains any of the normal IKAP function or
if it acquires new properties. To address this question we
generated mice carrying a deletion of exon 20 in the Ikbkap gene
(Ikbkap
D20/+; see Figure 2A). For this purpose Ikbkap
3loxP/+ mice
were crossed with a Cre ‘‘deletor’’ line [28]. Progeny carrying
both the targeted Ikbkap allele and the Cre transgene underwent
successful deletion of both the exon 20 and the neo cassette, and
transmitted the Ikbkap
D20/+ allele to their progeny (Fig. 2B). As
expected, Ikbkap
D20/+ mice were viable and fertile. However,
intercross of Ikbkap
D20/+ mice did not yield viable progeny (no
homozygous mutants was found at P1, data not shown).
Dissections of pregnant female mice at different time points
revealed that Ikbkap
D20/D20 embryos died around E11.5 and were
morphologically indistinguishable from Ikbkap
3loxP/3loxP embryos
(see below). Ikbkap expression in Ikbkap
D20/D20 and control
embryos was assessed by RT-PCR on total RNA at E10.5 using
sets of primers that amplify through exons 18 to 23. As shown in
Figure 2C, Ikbkap mRNA could be amplified from Ikbkap
D20/D20
embryos when primers spanning exons 18/19 or 21/23 were
used, but no product was amplified when one of the primers was
located in exon 20, confirming the production of a stable mRNA
lacking only exon 20.
Ikbkap mutant embryos are developmentally delayed
and display cardiovascular and brain malformations
To determine the nature of the developmental abnormalities of
Ikbkap
3loxP/3loxP and Ikbkap
D20/D20 mutants, and the cause of the
embryonic lethality, embryos derived from the respective hetero-
zygous intercrosses were dissected at different stages of gestation
from E8.5 to E10.5. Both types of mutations produced embryos
with practically identical phenotypes at all stages examined (see
below, table 1 and data not shown), confirming that the Ikbkap
D20
allele does not retain any Ikbkap biological activity.
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mutant embryos were already developmentally delayed (data not
shown). At E9.5 Ikbkap mutant embryos were significantly smaller
than their WT littermates and resembled WT E8.5 embryos in size
and general morphology (Fig. 3A–C), suggesting that development
of mutant embryos was approximately one day delayed relative to
their control littermates (Fig. 3D). Histological analyses of mutant
embryos at this stage confirmed that in mutant embryos cephalic
and cardiac development was similar to that of E8.5 control
embryos (Fig. 3H–J).
By E10.5, development of the mutant embryos had progressed,
and they had reached several of the developmental milestones of
E9.5 WT embryos: for instance, neural fold closing and turning of
the embryo had occurred, the lower mandibular process of the first
branchial arch had developed, the otic pit had become clearly
visible, and development of the limb buds had begun. Marked
differences however were noticed at this stage: compared to WT
E9.5 embryos, E10.5 mutant embryos were pale and their yolk-
sacs poorly vascularized, they did not develop a second branchial
arch, and exhibited severe brain and cardiac developmental
abnormalities (Fig. 3D–G and data not shown). Gross morpho-
logical inspection of the embryos indicated that although midbrain
and hindbrain regions appeared similar to that of E9.5 WT
embryos, development of the forebrain and in particular of the
telencephalon was markedly compromised.
The heart appeared severely abnormal in mutant embryos, and
in embryos recovered dead at E10.5 heart development had not
progressed further than an E8.5-like primitive heart (data not
shown). Hearts of mutant embryos that were alive at E10.5 (heart
beating) exhibited abnormal looping and dilated pericardium sacs
(Fig. 3E–G), although their development had progressed and
constriction of the atrial ventricular canal could be observed. At
E11.5, all mutants displayed severe pericardial effusion accompa-
nied by loss of heart-beat (data not shown). These observations
indicate that heart failure is most likely the cause of death of
Ikbkap mutant embryos.
Histological analysis of Ikbkap mutants
To further analyze the brain and cardiovascular developmen-
tal defects of mutant embryos, we performed histological analyses
on serial sections of E9.5 and E10.5 control and mutant
Ikbkap
3loxP/3loxP and Ikbkap
D20/D20 embryos. Histological examina-
tions confirmed that anterior development was particularly
affected in Ikbkap
3loxP/3loxP and Ikbkap
D20/D20 mutant embryos at
Figure 1. Targeted disruption of the mouse Ikbkap gene. (A) Schematic representation of wild-type allele (WT), Ikbkap targeting vector
(vector), and Ikbkap targeted allele (3loxP). Exons are represented by black rectangles, and black ovals represent the loxP sites. The position of the5 9
external probe along with the sizes of the diagnostic fragments are indicated. The positions of the primers used for genotyping are indicated by
numbered arrows (1, 2, 3, 4), also the position of the pgk oligo is marked by an arrow above the neo cassette. A loxP flanked neostop cassette (neo
HIS3-stop) is also indicated. Restriction sites shown on the schematic are: Bam HI (B), HindIII (H), BstXI (BX) and BstEII (BE). (B) Southern blot of WT
(lanes 1,4, 5, and 7) and targeted (lanes 2,3, and 6) ES clones, DNA digested with BamHI and probed with the 59 flank probe. (C) Genotyping of
progeny derived from Ikbkap
3loxP/+ intercross. Genomic DNA from WT (lane 1), heterozygous (lane 2) and homozygous (lane 3) progeny was amplified
by PCR using the primers Ikap1for and Ikap2rev 2. (D) RT-PCR on reverse transcribed RNA from WT (lanes 1 and 2) and Ikbkap
3loxP/3loxP (lanes 3 and 4)
embryos using the primers Ikap18for and Ikap23rev is depicted (top panel). b-actin amplification (bottom panel) was performed in parallel to verify
that equal amounts of starting material were used in each reaction.
doi:10.1371/journal.pone.0027015.g001
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expanded and the lamina terminalis (the most rostral part of the
telencephalon) was evident, in mutant embryos at E10.5 the
telencephalic vesicle was poorly developed and the lamina
terminalis could not be identified (Fig. 4A–F, and data not
shown). Formation of other anterior structures also appeared
compromised as there was no evidence of formation of the optic
vesicle in mutant embryos at E10.5, although this structure is
readily visible in E9.5 WT embryos (Fig. 4A, B, and D, E).
Histological analyses of diencephalon, midbrain and hindbrain
regions of mutant E10.5 embryos indicated that these structures
were grossly similar to the corresponding regions of WT E9.25-
E9.5 embryos although less expanded (Fig. 4, and data not shown).
Together these observations suggest that although IKAP is not
required for proper formation of the neuroepithelium itself, or for
neural tube closure, it is required for development of the forebrain
and other anterior structures.
Cardiac and vascular development was also severely compro-
mised in Ikbkap
3loxP/3loxP and Ikbkap
D20/D20 mutant embryos.
Although the dorsal aorta and cardinal veins could be easily
identified, they were invariably hypoplastic (Fig. 4G and H). In
agreement with a probable developmental delay of 1 day of
gestation, mutant hearts at E10.5 had not formed the endocardial
cushion, nor displayed the level of ventricular trabeculation
observed in WT E10.5 embryo hearts, but rather ventricular
development appeared comparable to the hearts of WT E9.5
embryos (Fig. 4I-O). However, consistent with the morphological
observation of abnormal heart looping, serial transverse sections
through the heart of mutant and control embryos at E10.5 and
E9.5 respectively, confirmed that the outflow tract was misaligned
in the mutant embryos (Figure 4I–L). These results indicate that
IKAP is essential for cardiovascular development during early
embryogenesis.
Molecular analyses of Ikbkap mutants
To investigate the molecular pathways underlying the abnormal
heart morphogenesis of the mutant embryos, we analyzed
expression of multiple genes involved in heart development. We
Figure 2. Generation of an Ikbkap allele lacking exon 20. (A) Schematic representation of wild-type allele (WT), Ikbkap
3loxP allele (3loxP), and
Ikbkap allele lacking exon 20 after Cre-mediated recombination (D20). Exons are represented by black rectangles, and black ovals represent the loxP
sites. The positions of the primers used for genotyping are indicated by numbered arrows (1, 2, 3, 4), also the position of the pgk oligo is marked by
an arrow above the neo cassette. A loxP flanked neostop cassette (neo HIS3-stop) is also indicated. Restriction sites shown on the schematic are: Bam
HI (B), HindIII (H), BstXI (BX) and BstEII (BE). (B) Genotyping of progeny derived from Ikbkap
D20/+ intercross. Genomic DNA from WT (lane 1),
heterozygous (lane 2) and homozygous (lane 3) progeny amplified by PCR using the primers Ikap1for Ikap4rev (top panel) and Ikap19for and Ikap4rev
(bottom panel). (C) Expression of Ikbkap was assessed by RT-PCR in WT (lanes 1 and 2) and homozygous (lanes 3 and 4) embryos using the primers
Ikap18for and Ikap19rev (top panel), Ikap20for and Ikap23rev, Ikap21for and Ikap23rev (middle panels). b-actin amplification (bottom panel) was
performed in parallel to verify that equal amounts of starting material were used in each reaction.
doi:10.1371/journal.pone.0027015.g002
Table 1. – Ikbkap
D20/D20 mutant embryos are identical to Ikbkap
3loxP/3loxPembryos.
E9.5 E10.5
Matings WT heterozygous Mutant
a,b WT heterozygous Mutant
a,c
Ikbkap
3loxP/+X Ikbkap
3loxP/+ 8 20 7 12 23 11(2)
Ikbkap
D20/+ X Ikbkap
D20/+ 10 21(1) 8(1) 9 24 10 (3)
Ikbkap
3loxP/+X Ikbkap
D20/+ 4 7 3 7 12 5 (1)
Total number of embryos recovered at each stage is indicated; number of dead embryos is included in parenthesis.
aMutant homozygous (Ikbkap
3loxP/3loxP or Ikbkap
D20/D20) or compound heterozygous (Ikbkap
3loxP/D20) embryos were recovered at Mendelian ratio at E9.5 and E10.5.
bThe majority of the embryos recovered were alive and appeared to be one day delayed.
c,75% of the embryos were alive, appeared to be one day delayed and exhibited impaired cephalic development and severe cardiac abnormalities, see results.
doi:10.1371/journal.pone.0027015.t001
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expression is restricted to the primitive heart at E8.5 and is
downregulated at E9.5-E10.5, as heart development progresses
[29,30]. Consistent with the histological analyses, Itb3 expression
was observed in E8.5 WT and E9.5 Ikbkap mutant embryos, and
was downregulated at later stages in both WT and mutants (Fig. 5),
confirming that at E9.5 mutant embryos display a primitive heart
similar to that of a WT E8.5 embryo. Downregulation of Itb3
transcripts at E10.5 in mutant embryos is also consistent with the
progression of heart development in the mutants.
Heart morphogenesis and development depends on a complex
regulatory network, and phenotypic analyses of mutant mice with
abnormal heart development has uncovered the involvement of
several genes in this process such as members of the Nkx2-5
homeobox transcription factor network (Nkx2-5, Gata4, Gata5,
Gata6, and Srf), and of the Bmp/Tgfb signaling pathway, in
which Smad4 acts as a key transcriptional co-activator [31–41].
Although semi-quantitative RT-PCR analyses on E8.5 - E10.5
control and mutant embryos did not reveal significant differences
in expression levels of Gata4, Nkx2-5 and Srf between mutant and
control embryos, expression of Smad4 and Gata5 was significantly
reduced in E10.5 mutants (about five-fold and four-fold reduction
respectively) compared to either E9.5 or E10.5 controls (Fig. 5).
The severe reduction in Smad4 expression prompted us to further
investigate the impact of IKAP loss on TGFb signaling. For this
purpose, we analyzed the expression of Bmp4 (an essential TGFb
superfamily member), and of two downstream direct targets of
Smad4, Inhibitor of DNA binding 1 (Id1) and plasminogen
activator inhibitor type 1 (Pai1), which are downregulated in
embryos lacking Smad4 in endothelial cells [38]. Although Bmp4
and Id-1 mRNA levels were unaltered in mutant embryos, Pai-1
expression was considerably reduced at E10.5 in mutant embryos
compared to either E9.5 or E10.5 WT embryos (Figure 5). Taken
together, our results indicate that loss of IKAP partially impairs
Smad4-dependent TGFb signaling in embryogenesis.
Discussion
Although it is generally believed that severe reduction of IKAP
expression is the leading or sole cause of FD [3,12,42,43], to date
Figure 3. Phenotypical features of mutant Ikbkap and control embryos. (A) Wild-type embryo at E8.5. Mutant Ikbkap
3loxP/3loxP (B) and
Ikbkap
D20/D20 (C) embryos at E9.5, photographed in the same magnification as the embryo shown in A. Note that mutant embryos at this stage
closely resemble the WT E8.5 embryo in size and external morphology. (D) WT embryo at E9.5 (different magnification than embryos in A–C). Note
that looping of the heart has already occurred at this stage. Ikbkap
3loxP/3loxP (E) and Ikbkap
D20/D20 (F) embryos at E10.5. In the mutants, anterior
cephalic development is severely compromised. In Ikbkap mutant embryos the forward growth of heart ventricle (v) occurred in the absence of
looping morphogenesis. Note the misaligned position of the outflow tract (oft) in mutant embryos compared to the embryo in D and the enlarged
pericardial sac (arrowhead). (G) E10.5 Ikbkap
D20/D20 (left) and WT (right) littermates photographed together. (H–J) H&E-stained sagital sections of E8.5
WT (H), E9.5 Ikbkap
3loxP/3loxP (I) and E9.5 wild-type (J) embryos. Note that at E9.5 cephalic and heart development of mutant embryos is similar to the
WT E8.5 embryo in H.
doi:10.1371/journal.pone.0027015.g003
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the truncated protein, which is produced due to skipping of exon
20 [10]. In order to understand the essential roles of IKAP during
embryonic development and to investigate the biological conse-
quences of exon 20 deletion, we have generated two mutations in
the mouse Ikbkap gene, and created two distinct alleles that result
in either loss of Ikbkap expression, or expression of an mRNA
lacking only exon 20. Our results show that in the mouse loss of
Ikbkap expression or expression of a truncated IKAP protein due
to deletion of exon 20 have identical biological consequences –
developmental delay and early embryonic lethality due to
abnormal cardiovascular development. These results prove for
the first time that the truncated IKAP protein does not retain any
significant biological function, at least during embryogenesis.
In agreement with our findings, Chen and collaborators [44] -
using a gene-trap ES cell line obtained from Bay Genomics/IGTC
- have recently demonstrated that inactivation of Ikbkap
expression in the mouse leads to early embryonic lethality
accompanied by severe growth retardation and developmental and
vascular abnormalities. However, their analyses relied solely on
morphology, and from their description and photographic docu-
mentation it is difficult to ascertain the range and degree of
developmental abnormalities of the mutant embryos. In addition, the
molecular analyses presented was restricted to one stage only (E8.5)
and did not take into account the already existing developmental
delay of Ikbkap knockout embryos, making the interpretation of the
differences in transcriptional profiles problematical.
Here we provide morphological, histological and molecular
evidence that show that loss of a functional IKAP protein leads to
a one day developmental delay, and that although mutant
embryos reach several milestones of a typical E9.5 embryo, they
display anterior cephalic developmental defects, and cardiovascu-
lar abnormalities with cardiac failure being most likely the leading
cause of early embryonic lethality.
Delayed development is an early feature of mutant embryos
already observed at E8.5 (data not shown), and by E9.5, although
Figure 4. Histological analyses of mutant Ikbkap and control embryos. (A–F) H&E-stained transverse sections through the head of E9.5 WT
(A and D), E10.5 Ikbkap
3loxP/3loxP (B and E) and E10.5 WT (C and F). A, B, D and E are shown in the same magnification for comparison. Note that the
telencephalic vesicle (tv) of the mutant embryo (E) is poorly developed compared to D and F. Note also that the lamina terminalis (lt) is absent in the
mutant (B), and that there is no evidence of formation of the optic vesicle (arrowhead). In contrast, the 4
th ventricle (4v) is well formed and
comparable to the control embryo in A. tg=trigeminal ganglion. (G and H) H&E-stained transverse sections at the level of the otic vesicle of E9.5 WT
(G) and E10.5 Ikbkap
3loxP/3loxP (H) embryos. Note that in the E10.5 mutant the otic vesicle (ot) has separated from the overlying surface ectoderm, a
landmark of normal development of E9.5 stage (G). Note that although the dorsal aorta (arrow) and cardinal vein (white arrowhead) are visible in the
mutant in H they are hypoplastic compared to the embryo in G. (I–N) H&E-stained transverse sections through the heart (rostral to caudal) of E9.5 WT
(I, K and M) and E10.5 Ikbkap
3loxP/3loxP embryos (J, L and N). Note the abnormal relative position of the outflow tract (oft) in the mutant heart (L)
compared to a normal embryo (K). The myocardium and also the level of trabeculation of the ventricle in the mutant (J and L) appear comparable to
an E9.5 control embryo (I and K). v=ventricle, a=atrium, Li=liver. Note that development of a WT E10.5 heart has proceeded significantly (O) with
extensive trabeculation, separation of left and right ventricles, and formation of the endocardial cushion (ec).
doi:10.1371/journal.pone.0027015.g004
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WT embryos as seen by morphological and histological analyses
(Fig. 3) as well as by RT-PCR amplification of the stage-specific
cardiac marker Itb3 (Fig. 5). By E10.5 however, although mutant
embryos had reached some of the milestones of E9.5 control
embryos, considerable abnormalities could be easily observed,
with cephalic and cardiac development being significantly
compromised (Fig. 3 and 4).
Although the cause of the developmental delay of IKAP mutant
embryos requires further investigation, it is possible that IKAP is
required for regulation of apoptotic programmed cell death and/
or cell proliferation during early embryogenesis. Embryos lacking
the zinc finger protein ZFR [45] display embryonic developmental
delay (as our Ikbkap mutant embryos), a delay that is caused by
increased cell death with concomitant decreased cell proliferation
in the epiblast at E6.0–E6.5. Increased cell death at the same
developmental stage leading to developmental delay was also
reported in embryos lacking the human Bloom syndrome gene
[46]. Also, further support for a putative role of IKAP in
regulation of cell death or proliferation is enhanced by the findings
that elimination of IKAP in vitro enhances basal expression of pro-
apoptotic p53-dependent genes [47] and decreases expression of
genes involved in cell proliferation [17].
Anterior development is also compromised in the absence of
IKAP (see Figures 3 and 4). While the midbrain and hindbrain
regions of E10.5 mutant embryos were similar to E9.5 WT
embryos, development of the forebrain - and more specifically of
the telencephalon - was severely compromised (Fig. 4). Although
by E9.5 development of the neuroepithelium in mutant embryos
was comparable to WT E8.5 embryos and did not exhibit signs of
increased cell death by H&E staining (Fig. 3, and data not shown),
decreased cell proliferation or aberrant patterning signals could
account for impaired anterior development. Of importance is our
finding that Smad4 expression is severely reduced in IKAP mutant
embryos. Smad4, a key mediator of Bmp/Tgfb signaling [35,36],
is directly implicated not only in cardiovascular development (see
below) but also in head and brain development, as embryos
lacking Smad4 expression in the embryo proper exhibit anterior
truncations [35]. It is possible therefore that the abnormal
formation of the telencephalon and of other anterior structures
in IKAP mutants is due to downregulation of Smad4-dependent
signaling (see Figure 5).
Even though the developmental defects of the mutant embryos
could be attributed to the need for IKAP in multiple processes,
cardiac failure is the most likely explanation for their early death
and could also explain their poor vascularization. Secondary
effects of hypoxia due to cardiac failure could also be responsible
for the abnormal development of anterior structures and including
the second pharyngeal arch. In vertebrate embryos, the cardio-
vascular system is the first organ system to develop, and in the
mouse, the hemodynamic force and blood flow generated by
embryonic heart-beat - between E8.5 and E9.5 - induce
remodeling of primitive vessels of the yolk sac to form a branched
network of large and small-caliber vessels, and also vascular
remodeling and angiogenesis in the embryo proper [48–53]. While
a functional primitive heart and large vessels are formed properly
(albeit with one day delay) in the absence of IKAP (Fig. 4), the
large vessels were invariably hypoplastic and vascular remodeling
of the yolk sac was severely compromised. Although many genes
that are required for vascular remodeling have a cell-autonomous
role in endothelial cells, mutations that affect primarily cardiac
development also cause abnormal vascular remodeling [51]. In
IKAP mutant embryos, heart looping - which occurs between
E8.75 and E9.25 in WT embryos [54,55] - is abnormal, and
Figure 5. Semi-quantitative RT-PCR analyses. Equal amount of
total RNA from control (C) and mutant (M, Ikbkap
D20/D20) embryos at
the indicated stages (E8.5-E10.5) was used for cDNA synthesis in the
presence of reverse transcriptase (RT) and the resulting cDNA was used
for amplification of the specified genes (see details in Materials and
Methods). Similar results were obtained for Ikbkap
3loxP/3loxP embryos
(data not shown). For negative control (-), reverse transcription reaction
was performed in the absence of RT using equal starting amounts of
total RNA as in all other reactions. Amplification of the rRNA 18S
(bottom panel) was used as internal control for normalization of cDNA
template quantity in the PCR reactions. As marker 100 bp ladder (L) is
also shown. Lack of Ikbkap amplification with oligos Ikbkap20for and
Ikbkap23rev in the upper most panel reconfirms the genotyping results
for the mutant (M) Ikbkap
D20/D20 embryos used for the depicted
analyses.
doi:10.1371/journal.pone.0027015.g005
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of looping morphogenesis, there is absence of atrioventricular
canal and misalignment of the outflow tract (Fig. 3 and 4). Similar
cardiac abnormalities were shown to be the primary cause of early
embryonic lethality and vascular remodeling defects in embryos
lacking cardiac expression of Nkx2-5 [31,32], Srf [41], and Tgfrb2
[56]. Notably, impaired contractility by itself was shown to be
sufficient to abolish vascular remodeling of the yolk sac in mice
[53]. These observations however do not rule out the possibility
that IKAP may also have a cell-autonomous function in
endothelial cells and as a result IKAP may also play a direct
role in vascular remodeling.
Since cardiovascular defects are prominent in Ikbkap null
embryos, we evaluated the impact of loss of IKAP in expression of
several genes involved in cardiac morphogenesis and vascular
remodeling. Surprisingly, we found that expression of several
major genes involved in cardiac development, including Gata4,
Nkx2-5 and Srf, was normal in E9.5 and E10.5 mutant embryos.
Interestingly, and while expression of Gata5 was significantly
lower in E9.5 mutants, expression of Gata5 and Smad4 was
severely reduced by E10.5 (Fig. 5). The essential roles of Gata5
during cardiogenesis in mice have only recently started to emerge.
Although it has long been reported that mice lacking Gata5 are
viable and do not display cardiac defects [57], Singh and
collaborators have recently shown that Gata4
+/-; Gata5
-/- mutants
die at mid-gestation with profound cardiovascular abnormalities
[58], suggesting a cooperative interaction between these transcrip-
tion factors during heart development. However, since expression
levels of Gata4 were unaltered in Ikbkap mutants (Fig. 5), the
biological significance of Gata5 downregulation in IKAP embryos
remains to be elucidated. In contrast, the essential roles of Smad4-
dependent TGFb signaling in cardiovascular development has
been extensively documented. For instance, loss of Smad4
expression in neural crest cells, cardiomyocytes, or endothelial
cells result in severe cardiovascular defects and embryonic lethality
[38,39,59]. In addition, disruption of TGFb signaling during
cardiogenesis leads to aberrant heart looping and impaired
remodeling of the atrioventricular canal [56]. Our results indicate
that reduction of Smad4 expression in mutant embryos leads to
significant downregulation of its downstream target Pai1, suggest-
ing that downregulation of Smad4 expression and consequent
disruption of TGFb signaling may be the primary cause of the
cardiovascular defects of IKAP mutant embryos.
Our findings also shed light to potential mechanisms underlying
FD pathology. First, we have shown that the truncated IKAP
protein expressed in FD due to exon 20 skipping does not retain
significant biological function, at least during embryogenesis. This
implies that most likely the reduction of IKAP expression is the
only cause of sensory and autonomic developmental defects of FD
patients, and also that even a very low level of full-length IKAP (as
seen in FD patients) is sufficient to carry on embryonic
development up to birth. Second, apart from its essential roles in
anterior and cardiovascular development, Smad4-dependent
TGFb signaling has also been shown to play an essential role in
development and maintenance of sensory and autonomic systems.
It has been shown that conditional inactivation of Smad4 in neural
crest cells does not affect neurogenesis and ganglia formation but
results in reduction of proliferation and noradrenergic differenti-
ation in sympathetic ganglia, and elimination of TrkA-positive
subpopulations in trigeminal ganglia [60,61]. Hence, in view of the
requirement of IKAP for regulation of Smad4 expression, it is
possible that disruption of TGFb signaling in neural crest cells may
contribute to FD pathology. Unfortunately, the developmental
delay associated with possible secondary effects of hypoxia, and
early death of mutant embryos lacking IKAP precludes the
analyses of the developmental status of the peripheral nervous
system at this point. Conditional inactivation of IKAP in specific
cell populations, and in particular in neural crest cells, should
elucidate the role(s) of IKAP in PNS development.
Materials and Methods
Construction of the targeting vector
An RT-PCR product (,660 bp corresponding to position
2360-3025 of the human IKAP cDNA, accession number
AF153419) was used as a probe to screen a mouse genomic
DNA library (Stratagene) for clones containing the Ikbkap mouse
sequence corresponding to human exons 18-21. We identified and
picked 3 phages that hybridized with our probe. Inserts were
isolated, cloned in a cosmid vector and characterized. A clone with
an 11 kb insert containing exon 20 was partially sequenced and
characterized with restriction endonucleases. A 5.8 kb HindIII
fragment and a 3.3 kb HindIII/NotI fragment of the Ikbkap
genomic clone were initially subcloned separately into pBluescript
and used as backbone for the generation of the targeting vector. A
loxP flanked neostop cassette [25] was then cloned into the unique
BstEII site of intron 20, and a loxP site was cloned into the BstXI
site in intron 19.
Generation of Ikbkap mutant mice
The targeting vector was linearized and introduced by
electroporation into W9.5 ES cells grown on mitomycin C-treated
G418-resistant primary mouse fibroblasts. After selection with G-
418 resistant ES clones were picked and expanded. DNA purified
from ES cells was analyzed by Southern blotting using a probe that
distinguishes between the targeted (Ikbkap
3loxP) and wild type alleles
(Fig. 1A). A neo probe was then used to verify that single copy
integration occurred in the targeted ES cells (data not shown).
Targeted ES cells were injected into the blastocoel cavity of
E3.5 C57BL/6 embryos using standard procedures [62]. Germ-
line chimeras were produced with three independent Ikbkap
3loxP/+
ES clones. Chimeras were backcrossed to C57BL/6 females that
yielded heterozygous progeny for the Ikbkap mutant allele.
To generate mice in which only exon 20 is deleted (Ikbkap
D20/+),
Ikbkap
3loxP/+ mice were crossed with a Cre deletor line [28]
maintained in C57BL/6 background. Progeny carrying both the
targeted Ikbkap allele and the Cre transgene underwent successful
deletion of exon 20 and the neo cassette, and transmitted the
Ikbkap
D20/+ allele to their progeny (Fig. 2). All protocols for animal
use were approved by the Institutional Animal Care and Use
Committee of the University of Tennessee, and were in
accordance with NIH guidelines.
PCR assays for genotyping
For routine genotyping genomic DNA was prepared from tail
biopsies or yolk sacs (embryos), and PCR amplification reactions
were carried in the following conditions: 35 cycles consisting of 45
sec denaturation at 94uC, 45 sec annealing at 61uC, and 1 min
extension at 72uC. The following primers were used for genotyping:
Ikap1for 59-TGATTGACACAGACTCTGGCCA-39, Ika-
p2rev 59-GGAGATCCTCTAAGCAGCAGG-39, Ikap3for 59-
CAGATTCGGAAGTGGCTGGAC-39, Ikap4rev 59-CTTTCA-
CTCTGAAATTACAGGAA-39, Ikap19for 59-GAGAAATTC-
TGCGGAAAGTGGAA-39 and pgk (pgk promoter sequence):
59-GCCCGGCATTCTGCACGCTT-39.
Diagnostic PCR reactions were the following:
Ikap1for and Ikap2rev amplify a 160 bp product from the wt
allele, and a 290 bp product from the targeted Ikbkap
3loxP allele;
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allele, and a 300 bp from the mutant Ikbkap
D20 allele; Ikap19for
and Ikap4rev amplify a 605 bp from the wt allele and 500 bp for
the Ikbkap
D20 allele.
Histological analyses
For histology, decidua derived from heterozygous intercrosses
were collected and fixed overnight in 4% (wt/vol) paraformalde-
hyde in phosphate-buffered saline (PBS); incubated for 24 hours at
4uC in PBS containing 0.25 M sucrose, 0.2 M glycine; dehydrat-
ed; cleared with toluene; and embedded in paraffin. Paraffin
blocks were sectioned at 7 mm, mounted onto superfrost slides
(Fisher), and selected slides were stained with hematoxylin and
eosin. Staging of embryos and corresponding histological sections
was performed according to Kaufmann [63].
Genotyping of paraffin-embedded embryos
Genotyping of paraffin-embedded and sectioned material was
carried out as described [64] with some modifications. Briefly
maternal deciduas were scraped out and slides were deparaffinized
in Citrisolv (Fisher), and re-hydrated in a series of decreasing
alcohol concentrations. Deparaffinized sections were scraped and
placed in eppendorf tubes containing 50 ml of 500 mM Tris
pH 8.8, 10 mM NaCl, 20 mM EDTA, 3% Tween 20, supple-
mented with 1.5 mg proteinase K (PK)/ml. After overnight
incubation in a 55uC water bath, samples were boiled for 10 min
and 2 ml was used as template for PCR amplification under
routine conditions for genotyping.
RT-PCR assays
Embryos derived from Ikbkap
3loxP/+ and Ikbkap
D20/+ intercrosses
were dissected at E8.5, E9.5 and E10.5. Yolk sacs were used for
genotyping and embryos were snap frozen and stored at –80uC
until needed. Total RNA was isolated from WT and mutant
embryos using Trizol reagent (GIBCO-BRL) according to the
manufacturer’s instructions. For reverse transcription (RT) 1 mg
total RNA was annealed with random hexamers, and first strand
cDNA synthesis was carried out using Superscript III reverse
transcriptase kit (Invitrogen). For assessment of gene expression,
1 ml of each RT reaction (equivalent to 50 ng of starting mRNA)
was used for semi-quantitative PCR amplification. All PCR
reactions were carried out in the same conditions: 45 sec
denaturation at 94uC, 45 sec annealing at 61uC, and 1 min
extension at 72uC.
The following pairs of primers were used: Ikap18for 59-
TCACGTCATTTGCTGTGTGTGAT-39 and Ikap19rev 59-C T -
TTGTGTCCTGGGGAACAACT-39 (195 bp product); Ikap21for
59ACCTCAATCTGATTCATGACCATA-39 and Ikap23rev
59-GGAGGGTACATGGTCTTTGTGA-39 (145 bp product);
Ikap20for 59-GAGGTTGTTCATCATCGGGCC-39 and Ika-
p23rev 59-GGAGGGTACATGGTCTTTGTGA-39 (245 bp pro-
duct); Ikap18for and Ikap23rev (see above, 475 bp product);
Itgb3for 59-AGTGTAAGAAGTTCAACCGGGG-39 and Itg-
b3rev 59-CTTCCAGATGAGCAGAGTAGCA-39 (300 bp prod-
uct); Gata5for 59-AGGCCACTGGCAATGAAAAAGG-39 and
Gata5rev 59-GGCCAGAGCACACCAGGTCT-39 (350 bp
product); Gata4for 59-CCATCCAGTGCTGTCTGCTCT-39
and Gata4rev 59-ACTTTGCTGGCCCCCACGTC-39 (205 bp
product); Srffor 59-TGCCCGCCACCATCATGACG-39 and
Srfrev 59-TCCCAGCTTGCTGCCCTATCA-39 (290 bp prod-
uct); Nkx2-5for 59-TTTTACCCGGGAGCCTACGGT-39 and
Nkx2-5rev 59-CCGCTGTTGCTTGAAGCGCC-39 (210 bp pro-
duct); Smad4for 59-ATCCTTCGGGAGGAGATCGCT-39 and
Smad4rev 59-CGCCTGTTGCTGCATCTGCC-39 (290 bp
product); Bmp4for 59- CTGGGGAGGAGGAGGAGGAA-39
and Bmp4rev 59- TGCTCCCGAAAGAGCCGGAG-39 (220 bp
product); Pai1for 59- CCCGCCTCCTCATCCTGCC-39 and
Pai1rev 59- TCGGGTTGTGCCGAACCACAA-39 (290 bp prod-
uct); Id1for 59- GCAGCAGGTGAACGTCCTGC-39 and Id1rev
59- ATGCGATCGTCGGCTGGAACA-39 (280 bp product).
For internal controls, b-actin mRNA or 18S rRNA were
amplified by PCR with 22 cycles consisting of 1 min denaturation
at 94uC, and 2 min annealing and extension at 72uC, or 17 cycles
consisting of 45 sec denaturation at 94uC, 45 sec annealing at
61uC, and 1 min extension at 72uC, respectively.
The primers used were: b-actinfor 59-GACAACGGCTCCGG-
CATGTGCAAAG-39, and b-actinrev 59-TTCACGGTTG-
GCCTTAGGGTTCAGGG-39 which amplify a 320 bp product,
and 18Sfor 59-GGTGGTGGTGCATGGCCGTT-39and 18Srev
59- GCAGCCCCGGACATCTAAGG -39 which amplify a
200 bp product.
In all cases, one third of the PCR reactions were fractionated in
2% agarose gels.
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